Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Mirion Technologies $150 million registered direct offering
We advised Mirion on the offering
Truist $1.95 billion sale of a stake in Truist Insurance to Stone Point Capital
We are advising Truist as the seller on this transaction
CureVac $250 million follow-on offering
We advised CureVac on the equity offering
Xponential Fitness $122.5 million secondary offering
We advised Xponential Fitness on the offering
Comcast $1 billion inaugural green bond offering
We advised Comcast on the investment-grade debt offering
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Morgan Stanley $2 billion subordinated reset notes offering
We advised Morgan Stanley on its SEC-registered global offering
Morgan Stanley $4 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering